EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ferroptosis Inducing Co(III) Polypyridine Sulfasalazine Complex for Therapeutically Enhanced Anticancer Therapy

Nicolás Montesdeoca, Lukas Johannknecht, Elizaveta Efanova, Jacqueline Heinen-Weiler, Johannes Karges iD

Angewandte Chemie International Edition · 25.11.2024 · 63 (48)

DOI: 10.1002/anie.202412585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 30.10.2024. Verfasst von Nicolás Montesdeoca und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780, Bochum, Germany. Hauptthemen laut MEDLINE: Ferroptosis, Sulfasalazine, Antineoplastic Agents, Cobalt. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Verband der Chemischen Industrie, Aventis Foundation, Paul-Ehrlich-Gesellschaft Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite significant improvements in the treatment of cancerous tumors in the last decades, cancer remains one of the deadliest diseases worldwide. To overcome the shortcomings of currently applied chemotherapeutic treatments, much research efforts have been devoted towards the development of ferroptosis inducing anticancer agents. Ferroptosis is a newly described form of regulated, non‐apoptotic cell death that is associated with high potential inside the clinics. Herein, the chemical synthesis and biological evaluation of a Co(III) polypyridine sulfasalazine complex as a ferroptosis inducer is reported. Upon entering the cancerous cells, the metal complex primarily accumulated in the mitochondria, triggering the production of hydroxy radicals and lipid peroxides, ultimately causing cell death by ferroptosis. The compound demonstrated to eradicate various monolayer cancer cells as well as colon carcinoma multicellular tumor spheroids. To the best of our knowledge this study reports on the first example of a Co(III) complex that is capable of inducing ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisSulfasalazineAntineoplastic AgentsCobaltPyridinesCoordination ComplexesHumansCell Line, TumorDrug Screening Assays, AntitumorCell Proliferation

Stichwörter der Autor:innen

AnticancerBioinorganic ChemistryFerroptosisMedicinal Inorganic ChemistryMetals in Medicine

Substanzen

SulfasalazineAntineoplastic AgentsCobaltPyridinesCoordination Complexes

Autor:innen und Institutionen

  • Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Universitätsstrasse 150, 44780, Bochum, Germany.
  • Medical Imaging Center (MIC), Electron Microscopy Medical Analysis - Core Facility (EMMACF) Faculty of Medicine, Ruhr-University Bochum, Universitätsstrasse 150, 44780, Bochum, Germany.

ORCID-Profile: Johannes Karges

Förderung

  • Verband der Chemischen Industrie
  • Aventis Foundation
  • Paul-Ehrlich-Gesellschaft Stiftung

Zitieren

APA

Montesdeoca, N., Johannknecht, L., Efanova, E., Heinen-Weiler, J., & Karges, J. (2024). Ferroptosis Inducing Co(III) Polypyridine Sulfasalazine Complex for Therapeutically Enhanced Anticancer Therapy. Angewandte Chemie International Edition, 63(48). https://doi.org/10.1002/anie.202412585

Vancouver

Montesdeoca N, Johannknecht L, Efanova E, Heinen-Weiler J, Karges J. Ferroptosis Inducing Co(III) Polypyridine Sulfasalazine Complex for Therapeutically Enhanced Anticancer Therapy. Angewandte Chemie International Edition. 2024;63(48). doi:10.1002/anie.202412585

BibTeX
@article{Montesdeoca2024,
  author = {Montesdeoca, Nicolás and Johannknecht, Lukas and Efanova, Elizaveta and Heinen-Weiler, Jacqueline and Karges, Johannes},
  title = {Ferroptosis Inducing Co(III) Polypyridine Sulfasalazine Complex for Therapeutically Enhanced Anticancer Therapy},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  volume = {63},
  number = {48},
  doi = {10.1002/anie.202412585}
}
Kostenlos starten →